Mutations causing syndromic autism define an axis of synaptic pathophysiology.
about
5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophreniaAutistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor functionAutism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors.Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.SYNGAP1: Mind the GapProteostasis and RNA Binding Proteins in Synaptic Plasticity and in the Pathogenesis of Neuropsychiatric DisordersAutism Spectrum Disorders and Drug Addiction: Common Pathways, Common Molecules, Distinct Disorders?New Therapeutic Options for Autism Spectrum Disorder: Experimental EvidencesBehavioral phenotypes of genetic mouse models of autism.Characterizing autism spectrum disorders by key biochemical pathways.Genes, circuits, and precision therapies for autism and related neurodevelopmental disordersDysregulation and restoration of translational homeostasis in fragile X syndromeDysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of AutismExcitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum DisordersThe neurology of mTORiPSC-derived neurons as a higher-throughput readout for autism: promises and pitfallsAutism spectrum disorders and neuropathology of the cerebellumA genetic model for neurodevelopmental diseaseCellular and synaptic network defects in autismHarnessing the power of metabolism for seizure prevention: focus on dietary treatmentsDendritic spine dysgenesis in autism related disordersTreatment of neurodevelopmental disorders in adulthoodAn autism case history to review the systematic analysis of large-scale data to refine the diagnosis and treatment of neuropsychiatric disordersThe pathophysiology of fragile X (and what it teaches us about synapses)ROS and brain diseases: the good, the bad, and the uglyGenomics and autism spectrum disorderNeuroligins provide molecular links between syndromic and nonsyndromic autismInhibition-Based Biomarkers for Autism Spectrum Disorder.Potential for treatment of severe autism in tuberous sclerosis complexTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesPremature changes in neuronal excitability account for hippocampal network impairment and autistic-like behavior in neonatal BTBR T+tf/J mice.Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice.Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and BackAdvancing the understanding of autism disease mechanisms through geneticsmTOR and MAPK: from localized translation control to epilepsySynaptopathies: synaptic dysfunction in neurological disorders - A review from students to studentsProfile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapyLTD-like molecular pathways in developmental synaptic pruningHuman variants in the neuronal basic helix-loop-helix/Per-Arnt-Sim (bHLH/PAS) transcription factor complex NPAS4/ARNT2 disrupt functionFMRP targets distinct mRNA sequence elements to regulate protein expression
P2860
Q24299992-A341A4CA-EF2E-4868-BEE7-6E8789461B20Q24338263-1C3D6CDE-15D4-4787-AA72-C61650288568Q26269833-71140419-BCCF-4712-B127-EF651A3E0C22Q26748761-C2C8493B-925C-4196-BCCF-67230605DC3EQ26766506-381D04F2-8EAD-4130-8A93-03244C3021A4Q26767347-1A4F613B-A00E-4752-8C98-3A8572D80DC3Q26768231-240D2BEA-2667-4800-87D5-7DA21AA321F8Q26771762-8653B129-506D-423D-AFF1-D3ACE7650470Q26781456-B04CEAB2-F8EB-4182-A9F0-6F6D47F23728Q26781645-4120ED53-7FD6-4F7C-B71F-CA0FC230272CQ26782594-3ABD4AB8-F5DD-4FE8-B9E1-AAB660EE9BFBQ26782616-37FED3E9-588B-4BB9-808F-F6A67D6AC589Q26782948-3922F036-D67E-4667-97FF-7335ACAC03F5Q26796321-132F3462-5B23-4D33-A88B-4EDF73A7FB3DQ26824286-757126DB-E9E9-4960-A420-654190F4CBFCQ26827249-4BDC58F1-D237-4293-B7C8-3C0468BAE237Q26853603-74FD966B-563D-4135-BDB0-FC259250D9C7Q26860566-4E8BC164-6C62-408A-B492-3EC100ECBBF0Q26864843-E0FD0215-8DA3-4EE0-B915-FF710560F358Q26991869-30AF241F-994D-49C3-8BC6-A373D0D97155Q26995242-C39D3775-5164-40E8-B790-3AF07C6896D6Q27000307-35A41CDB-265C-470E-A284-963563A124CFQ27008961-84E9EA05-0870-46AF-8707-0A901845D67AQ27010675-7ACF07E5-80B0-4A59-8731-1CD1F0973925Q27014070-B8527F0C-E269-4F00-9AC5-B2C8BB32E5E8Q27015042-684B0555-7B02-4F79-B24E-C1C827D99D98Q27015370-B0EE26FC-3590-46C8-8083-166BE2848708Q27015696-39E6AB6D-8E1D-4AC9-A797-288577F9A9BDQ27021739-7F7D2E03-31DE-45A9-AA93-3358F4546F4FQ27023257-A4803043-1E43-4CAF-8FF5-FB9D7A0BA924Q27316607-67047310-E270-49F7-95EF-161B5A15FDD4Q27318675-8EE8D4BB-BDF3-4860-8851-47DEE58D34C2Q27337360-91F7A13B-294C-4BDB-8A23-4972F326E46DQ28069757-CB1490A6-6AB5-4468-8324-7993A7CC4545Q28076827-65B87D73-CD31-41A0-B588-20DC9B8DC65CQ28077671-13FF2B9C-1847-4E7B-AF66-387228200647Q28078328-1D757195-70B1-4EF2-8D0E-E85D19E8652AQ28079060-0D996AA6-CF48-43D6-B96C-59C797E2A504Q28115497-6E44AC54-426F-4293-AAD1-66EE7CD566C5Q28117931-481226CA-2983-47CA-910A-3D8715A5A397
P2860
Mutations causing syndromic autism define an axis of synaptic pathophysiology.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mutations causing syndromic autism define an axis of synaptic pathophysiology.
@ast
Mutations causing syndromic autism define an axis of synaptic pathophysiology.
@en
type
label
Mutations causing syndromic autism define an axis of synaptic pathophysiology.
@ast
Mutations causing syndromic autism define an axis of synaptic pathophysiology.
@en
prefLabel
Mutations causing syndromic autism define an axis of synaptic pathophysiology.
@ast
Mutations causing syndromic autism define an axis of synaptic pathophysiology.
@en
P2860
P356
P1433
P1476
Mutations causing syndromic autism define an axis of synaptic pathophysiology.
@en
P2093
Benjamin D Auerbach
Mark F Bear
P2860
P2888
P356
10.1038/NATURE10658
P407
P577
2011-11-23T00:00:00Z
P5875
P6179
1040396263